精神分裂症多基因风险对心脏结构与功能的影响:UK Biobank观察性研究
该研究基于UK Biobank中32 279名无精神分裂症诊断的白人英国或爱尔兰裔参与者的心脏磁共振数据,探索精神分裂症多基因风险评分与心脏表型的关联。主成分分析显示多基因风险评分与第一主成分负相关,该主成分反映心脏容积增大、绝对峰值舒张应变率升高和射血分数降低。个体表型分析发现多基因风险评分与右心室收缩末期容积、舒张末期容积和绝对纵向峰值舒张应变率负相关,与右心室射血分数正相关。TGF-β和急性炎症通路特异性多基因风险评分也与主成分显著相关,且部分心脏表型与精神分裂症存在遗传重叠。
要点
- 精神分裂症多基因风险评分越高,右心室容积越小、射血分数越高、绝对峰值舒张应变率越低。
- 绝对峰值舒张应变率降低提示心肌僵硬度增加和舒张功能障碍,可能增加心脏病风险。
- TGF-β和炎症通路可能参与介导,部分心脏表型与精神分裂症存在遗传重叠。
核心结论
- 高精神分裂症多基因风险评分与心脏容积减小、射血分数增高和绝对峰值舒张应变率降低相关。
- TGF-β和炎症通路可能参与,部分心脏表型与精神分裂症存在遗传重叠。
- 绝对峰值舒张应变率降低提示心肌僵硬度增加和舒张功能障碍,增加心脏病风险。
研究设计与样本
- 观察性研究,使用UK Biobank数据,纳入无精神分裂症诊断的白人英国或爱尔兰裔个体。
- 采用主成分分析和回归分析,并用稳健回归探索多基因风险评分与个体心脏表型的关联。
- 重复分析使用TGF-β通路和急性炎症通路特异性多基因风险评分。
- 使用连锁不平衡得分回归探究精神分裂症与心脏表型的全基因组共享变异。
临床怎么用
- 精神科医生应关注精神分裂症遗传高风险者的心脏舒张功能,即使无传统心血管危险因素。
- 对精神分裂症患者进行心血管风险评估时,可考虑遗传背景对心脏结构的潜在影响。
- 未来需进一步研究确定这些关联是否特定于精神分裂症或其他精神疾病。
局限性
- 研究仅纳入白人英国或爱尔兰裔个体,结果外推至其他人群需谨慎。
- 研究为观察性设计,不能确立因果关系。
- 参与者均无精神分裂症诊断,结论不能直接推广至精神分裂症患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiovascular disease is a major cause of excess mortality in people with schizophrenia. Several factors are responsible, including lifestyle and metabolic effects of antipsychotics. However, variations in cardiac structure and function are seen in people with schizophrenia in the absence of cardiovascular disease risk factors and after accounting for lifestyle and medication. Therefore, we aimed to explore whether shared genetic causes contribute to these cardiac variations. METHODS: For this observational study, we used data from the UK Biobank and included White British or Irish individuals without diagnosed schizophrenia with variable polygenic risk scores for the condition. To test the association between polygenic risk score for schizophrenia and cardiac phenotype, we used principal component analysis and regression. Robust regression was then used to explore the association between the polygenic risk score for schizophrenia and individual cardiac phenotypes. We repeated analyses with fibro-inflammatory pathway-specific polygenic risk scores for schizophrenia. Last, we investigated genome-wide sharing of common variants between schizophrenia and cardiac phenotypes using linkage disequilibrium score regression. The primary outcome was principal component regression. FINDINGS: Of 33 353 individuals recruited, 32 279 participants had complete cardiac MRI data and were included in the analysis, of whom 16 625 (51·5%) were female and 15 654 (48·5%) were male. 1074 participants were excluded on the basis of incomplete cardiac MRI data (for all phenotypes). A model regressing polygenic risk scores for schizophrenia onto the first five cardiac principal components of the principal components analysis was significant (F=5·09; p=0·00012). Principal component 1 captured a pattern of increased cardiac volumes, increased absolute peak diastolic strain rates, and reduced ejection fractions; polygenic risk scores for schizophrenia and principal component 1 were negatively associated (β=-0·01 [SE 0·003]; p=0·017). Similar to the principal component analysis results, for individual cardiac phenotypes, we observed negative associations between polygenic risk scores for schizophrenia and indexed right ventricular end-systolic volume (β=-0·14 [0·04]; p=0·0013, pFDR=0·015), indexed right ventricular end-diastolic volume (β=-0·17 [0·08]); p=0·025; pFDR=0·082), and absolute longitudinal peak diastolic strain rates (β=-0·01 [0·003]; p=0·0024, pFDR=0·015), and a positive association between polygenic risk scores for schizophrenia and right ventricular ejection fraction (β=0·09 [0·03]; p=0·0041, pFDR=0·015). Models examining the transforming growth factor-β (TGF-β)-specific and acute inflammation-specific polygenic risk scores for schizophrenia found significant associations with the first five principal components (F=2·62, p=0·022; F=2·54, p=0·026). Using linkage disequilibrium score regression, we observed genetic overlap with schizophrenia for right ventricular end-systolic volume and right ventricular ejection fraction (p=0·0090, p=0·0077). INTERPRETATION: High polygenic risk scores for schizophrenia are associated with decreased cardiac volumes, increased ejection fractions, and decreased absolute peak diastolic strain rates. TGF-β and inflammatory pathways might be implicated, and there is evidence of genetic overlap for some cardiac phenotypes. Reduced absolute peak diastolic strain rates indicate increased myocardial stiffness and diastolic dysfunction, which increases risk of cardiac disease. Thus, genetic risk for schizophrenia is associated with cardiac structural changes that can worsen cardiac outcomes. Further work is required to determine whether these associations are specific to schizophrenia or are also seen in other psychiatric conditions. FUNDING: National Institute for Health Research, Maudsley Charity, Wellcome Trust, Medical Research Council, Academy of Medical Sciences, Edmond J Safra Foundation, British Heart Foundation.
引用
- Pillinger T, Osimo EF, de Marvao A, et al. Effect of polygenic risk for schizophrenia on cardiac structure and function: a UK Biobank observational study. Lancet Psychiatry. 2023. PMID: 36632818. doi:10.1016/S2215-0366(22)00403-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。